PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER- A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74348-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)74348-5/fulltext
Section Title :
Section Order :
273
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74348-5&doi=10.1016/S1098-3015(10)74348-5